- Published on
Pathology - Somatization Disorder
Of the five somatoform illnesses, somatization disorder is a highly specific diagnosis. It involves a history of several medical symptoms that started before the age of thirty and persisted for a number of years, either requiring treatment or seriously impairing social or vocational functioning. Four pain symptoms (relating to at least four different sites or functions), two gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), one sexual or reproductive symptom (e.g., irregular menses, sexual dysfunction), and one pseudoneurological symptom (e.g., impaired coordination, weakness, double vision) that cannot be explained by a physical or laboratory examination are all required to be included in the complaints. Unlike factitious disorder, when the patient's aim is to seem to be ill, or malingering, where there are extrinsic incentives like financial gain, this condition's symptoms are the product of unconscious psychological variables and are not purposefully manufactured. Related disorders include conversion disorder, which is characterized by one or more neurologic symptoms impairing voluntary motor or sensory function, and pain disorder, which is primarily focused on pain at one or more anatomical sites.
Of the five somatoform illnesses, somatization disorder is a highly specific diagnosis. It involves a history of several medical symptoms that started before the age of thirty and persisted for a number of years, either requiring treatment or seriously impairing social or vocational functioning. Four pain symptoms (relating to at least four different sites or functions), two gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), one sexual or reproductive symptom (e.g., irregular menses, sexual dysfunction), and one pseudoneurological symptom (e.g., impaired coordination, weakness, double vision) that cannot be explained by a physical or laboratory examination are all required to be included in the complaints. Unlike factitious disorder, when the patient's aim is to seem to be ill, or malingering, where there are extrinsic incentives like financial gain, this condition's symptoms are the product of unconscious psychological variables and are not purposefully manufactured. Related disorders include conversion disorder, which is characterized by one or more neurologic symptoms impairing voluntary motor or sensory function, and pain disorder, which is primarily focused on pain at one or more anatomical sites.
- Published on
Pathology - Anterior Hypopituitarism
The secretion of many anterior pituitary tropins has diminished. Lesions to the pituitary gland, pituitary stalk, or hypothalamus may be the cause of the illness.
Pituitary tumors, brain tumors, granulomas, cysts, and other mass lesions can all induce hypopituitarism. It can also happen in situations when there are no mass lesions, such as in cases of trauma, ischemia, radiation therapy, or hereditary disorders. This patient's visual field deficits and headache indicate that there may be a mass lesion pressing on the optic chiasm, which is situated just above the pituitary gland. Secondary hypothyroidism (low TSH) is most likely associated with symptoms such as weight gain, constipation, weariness, skin lesions, hypercholesterolemia, and hypoactive reflexes. Reduced follicle-stimulating hormone (FSH) and leptin release is the cause of secondary amenorrhea.
Hypotension, hyponatremia, inability to handle stress, and low cortisol and adrenaline levels all point to an ACh shortage. Which tropin is involved would become clear with additional testing. In this instance, an MRI would most likely show a mass lesion. In the end, transsphenoidal tumor excision is used to treat this problem. Pituitary hormone replacement treatment is then administered. Although the patient does not currently have posterior pituitary involvement, following surgery, vasopressin replacement is probably going to be necessary.
The secretion of many anterior pituitary tropins has diminished. Lesions to the pituitary gland, pituitary stalk, or hypothalamus may be the cause of the illness.
Pituitary tumors, brain tumors, granulomas, cysts, and other mass lesions can all induce hypopituitarism. It can also happen in situations when there are no mass lesions, such as in cases of trauma, ischemia, radiation therapy, or hereditary disorders. This patient's visual field deficits and headache indicate that there may be a mass lesion pressing on the optic chiasm, which is situated just above the pituitary gland. Secondary hypothyroidism (low TSH) is most likely associated with symptoms such as weight gain, constipation, weariness, skin lesions, hypercholesterolemia, and hypoactive reflexes. Reduced follicle-stimulating hormone (FSH) and leptin release is the cause of secondary amenorrhea.
Hypotension, hyponatremia, inability to handle stress, and low cortisol and adrenaline levels all point to an ACh shortage. Which tropin is involved would become clear with additional testing. In this instance, an MRI would most likely show a mass lesion. In the end, transsphenoidal tumor excision is used to treat this problem. Pituitary hormone replacement treatment is then administered. Although the patient does not currently have posterior pituitary involvement, following surgery, vasopressin replacement is probably going to be necessary.
- Published on
Pathology - Acromegaly
Excess growth hormone (GH) secretion is the cause of amegaly.
Excess GH secretion from a pituitary adenoma is nearly always the cause. Prolactin secretion and TSH secretion disruption are frequently present together, yet the patient in question does not have these complicating issues. The pituitary mass's pressure on the optic chiasm causes headache and temporal hemianopia. GH primarily stimulates the liver and other tissues to secrete more IGF-1, which in turn promotes somatic growth. Giantantism occurs in young patients prior to the closure of the epiphyseal growth plates. Acromegaly is characterized by the unique expansion of the skull, hands, feet, and facial characteristics in mature humans. Internal organ growth also takes place, with cardiomegaly being of special concern. Although its cause is unknown, hypertension is a common occurrence in individuals with anemia. People with excess GH often have insulin resistance and may develop diabetes mellitus (DM), as this patient did. This is because GH is generally an anti-insulin hormone that helps to maintain blood glucose levels in response to stresses. Transsphenoidal microsurgery, which removes the pituitary adenoma, is the preferred treatment and is effective in about 70% of cases.
Excess growth hormone (GH) secretion is the cause of amegaly.
Excess GH secretion from a pituitary adenoma is nearly always the cause. Prolactin secretion and TSH secretion disruption are frequently present together, yet the patient in question does not have these complicating issues. The pituitary mass's pressure on the optic chiasm causes headache and temporal hemianopia. GH primarily stimulates the liver and other tissues to secrete more IGF-1, which in turn promotes somatic growth. Giantantism occurs in young patients prior to the closure of the epiphyseal growth plates. Acromegaly is characterized by the unique expansion of the skull, hands, feet, and facial characteristics in mature humans. Internal organ growth also takes place, with cardiomegaly being of special concern. Although its cause is unknown, hypertension is a common occurrence in individuals with anemia. People with excess GH often have insulin resistance and may develop diabetes mellitus (DM), as this patient did. This is because GH is generally an anti-insulin hormone that helps to maintain blood glucose levels in response to stresses. Transsphenoidal microsurgery, which removes the pituitary adenoma, is the preferred treatment and is effective in about 70% of cases.
- Published on
Pathology - Hyperprolactinemia
Overabundance of prolactin suppresses the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which lowers the release of LH and FSH. Due to this, the patient's ovarian and menstrual cycles have been severely disrupted, leading to anovulation and secondary amenorrhea. Male libido reduction, erectile dysfunction, and hypogonadotropic hypogonadism are all brought on by hyperprolactinemia. Hyperprolactinemia can have a variety of reasons, such as physiological ones like pregnancy, pathologic ones like prolactinoma, and pharmacologic side effects like antipsychotic treatment. Hypothalamic dopamine is the primary regulator of anterior pituitary secretory inhibition of prolactin production. Larger secretory tumors are surgically removed, while hyperprolactinemia is treated with oral synthetic dopamine agonists (e.g., cabergoline, bromocriptine).
Overabundance of prolactin suppresses the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus, which lowers the release of LH and FSH. Due to this, the patient's ovarian and menstrual cycles have been severely disrupted, leading to anovulation and secondary amenorrhea. Male libido reduction, erectile dysfunction, and hypogonadotropic hypogonadism are all brought on by hyperprolactinemia. Hyperprolactinemia can have a variety of reasons, such as physiological ones like pregnancy, pathologic ones like prolactinoma, and pharmacologic side effects like antipsychotic treatment. Hypothalamic dopamine is the primary regulator of anterior pituitary secretory inhibition of prolactin production. Larger secretory tumors are surgically removed, while hyperprolactinemia is treated with oral synthetic dopamine agonists (e.g., cabergoline, bromocriptine).
- Published on
Pathology - Diabetes Insipidus
Large amounts of diluted urine (up to 20 L/d) are passed due to a deficit in pee concentrating ability caused by a relative lack of vasopressin release from the posterior pituitary. Patients need to drink a lot of water to make up for the water they lose through urine in order to maintain normal plasma osmolarity. Hypernatremia and dehydration ensue if the patient lacks access to enough drinking water or has a malfunctioning thirst mechanism. Vasopressin secretion can be lost due to secondary causes like infection, trauma, or tumor metastasis, or it might have a fundamental cause like autoimmune illness. V2-receptor agonists, such as desmopressin, can be used to treat patients with central DI since their renal tubules are healthy and responsive to vasopressin. Because corticosteroid drugs increase the excretion of free water, the patient's continuous corticosteroid treatment is a complicating complication. Nephrogenic DI is characterized by comparable symptoms but is caused by a relative absence of renal responsiveness to vasopressin, which the pituitary gland continues to secrete regularly. Both congenital and acquired conditions, such as pyelonephritis, renal amyloidosis, potassium depletion, and lithium therapy, can result in nephrogenic DI. Vasopressin derivatives are not effective in treating nephrogenic DI.
Large amounts of diluted urine (up to 20 L/d) are passed due to a deficit in pee concentrating ability caused by a relative lack of vasopressin release from the posterior pituitary. Patients need to drink a lot of water to make up for the water they lose through urine in order to maintain normal plasma osmolarity. Hypernatremia and dehydration ensue if the patient lacks access to enough drinking water or has a malfunctioning thirst mechanism. Vasopressin secretion can be lost due to secondary causes like infection, trauma, or tumor metastasis, or it might have a fundamental cause like autoimmune illness. V2-receptor agonists, such as desmopressin, can be used to treat patients with central DI since their renal tubules are healthy and responsive to vasopressin. Because corticosteroid drugs increase the excretion of free water, the patient's continuous corticosteroid treatment is a complicating complication. Nephrogenic DI is characterized by comparable symptoms but is caused by a relative absence of renal responsiveness to vasopressin, which the pituitary gland continues to secrete regularly. Both congenital and acquired conditions, such as pyelonephritis, renal amyloidosis, potassium depletion, and lithium therapy, can result in nephrogenic DI. Vasopressin derivatives are not effective in treating nephrogenic DI.
- Published on
Pathology - Hashimoto's disease
Lack of active thyroid hormones (T3 and T4) can lead to a variety of problems, such as a slowed metabolic rate, which is often associated with weariness, weight gain, and a cold sensitivity.
Bradycardia results from a drop in beta-adrenergic tone, which is dependent on thyroid hormones for proper beta-adrenergic system function. Additionally, isolated alpha-adrenergic vasoconstriction without concurrent beta-adrenergic receptor activation commonly results in diastolic hypertension. Hyponatremia and fluid retention are caused by renal failure. A thyroid hormone deficit impairs the neurological system's ability to function, resulting in diminished reflexes and mentation. Due to a buildup of mucopolysaccharides in interstitial tissues, this patient has myxedema from persistent hypothyroidism, which exacerbates peripheral edema and gives the skin a swollen appearance. The absence of negative feedback from active thyroid hormone leads to elevated TSH levels, which suggests primary hypothyroidism in the patient. Excess TSH leads to the thyroid gland's enlargement and the development of goiters as a result. This patient has been diagnosed with Hashimoto's thyroiditis, an autoimmune disease that is the most frequent cause of hypothyroidism in the United States, based on antibody titers. Iodine shortage in the diet and gland destruction from radiation, surgery, or chemotherapy are two more reasons of hypothyroidism. In rare cases, hypothalamic/pituitary stimulation deficiency causes hypothyroidism; in these cases, goiter is absent and TSH levels are low.
Lack of active thyroid hormones (T3 and T4) can lead to a variety of problems, such as a slowed metabolic rate, which is often associated with weariness, weight gain, and a cold sensitivity.
Bradycardia results from a drop in beta-adrenergic tone, which is dependent on thyroid hormones for proper beta-adrenergic system function. Additionally, isolated alpha-adrenergic vasoconstriction without concurrent beta-adrenergic receptor activation commonly results in diastolic hypertension. Hyponatremia and fluid retention are caused by renal failure. A thyroid hormone deficit impairs the neurological system's ability to function, resulting in diminished reflexes and mentation. Due to a buildup of mucopolysaccharides in interstitial tissues, this patient has myxedema from persistent hypothyroidism, which exacerbates peripheral edema and gives the skin a swollen appearance. The absence of negative feedback from active thyroid hormone leads to elevated TSH levels, which suggests primary hypothyroidism in the patient. Excess TSH leads to the thyroid gland's enlargement and the development of goiters as a result. This patient has been diagnosed with Hashimoto's thyroiditis, an autoimmune disease that is the most frequent cause of hypothyroidism in the United States, based on antibody titers. Iodine shortage in the diet and gland destruction from radiation, surgery, or chemotherapy are two more reasons of hypothyroidism. In rare cases, hypothalamic/pituitary stimulation deficiency causes hypothyroidism; in these cases, goiter is absent and TSH levels are low.
- Published on
Pathology -Graves'Disease
Increased metabolic rate and extensive disturbance brought on by high thyroid hormone levels frequently result in heat sensitivity and weight loss. The betaadrenergic system's overactivity causes hypertension, arrhythmias, and tachycardia, among other cardiovascular consequences. The most frequent cause of hyperthyroidism, which arises from the creation of TSI, is Graves' disease, which this patient has.
The overproduction of thyroid hormones is caused by these autoantibodies, which function as TSH receptor agonists. Additionally, the gland is growing and there is more vascularization (the bruit over the gland is indicative of this). Excess thyroid hormones have a negative feedback loop that lowers TSH levels.
A third of patients develop Graves' ophthalmopathy as a result of TSI and periorbital tissue cross-reactivity. Thyroid toxic adenomas and iodine-containing drugs like amiodarone, an anti-arrhythmic, are two more causes of hyperthyroidism.
It is uncommon to have secondary hyperthyroidism brought on by a tumor that secretes TSH. Thiourea medications are used to treat Graves' disease because they block the enzyme thyroid peroxidase, which lowers the production of thyroid hormones. It can also be necessary to have surgery or use radioactive iodine for gland ablation.
Increased metabolic rate and extensive disturbance brought on by high thyroid hormone levels frequently result in heat sensitivity and weight loss. The betaadrenergic system's overactivity causes hypertension, arrhythmias, and tachycardia, among other cardiovascular consequences. The most frequent cause of hyperthyroidism, which arises from the creation of TSI, is Graves' disease, which this patient has.
The overproduction of thyroid hormones is caused by these autoantibodies, which function as TSH receptor agonists. Additionally, the gland is growing and there is more vascularization (the bruit over the gland is indicative of this). Excess thyroid hormones have a negative feedback loop that lowers TSH levels.
A third of patients develop Graves' ophthalmopathy as a result of TSI and periorbital tissue cross-reactivity. Thyroid toxic adenomas and iodine-containing drugs like amiodarone, an anti-arrhythmic, are two more causes of hyperthyroidism.
It is uncommon to have secondary hyperthyroidism brought on by a tumor that secretes TSH. Thiourea medications are used to treat Graves' disease because they block the enzyme thyroid peroxidase, which lowers the production of thyroid hormones. It can also be necessary to have surgery or use radioactive iodine for gland ablation.
- Published on
Pathology - Primary Hypoparathyroidism
This can be acquired as a consequence of thyroid surgery, but in this instance, it is congenital or brought on by an autoimmune condition. Hypocalcemia is brought on by the incapacity of PTH loss to keep serum calcium (and, to a lesser degree, magnesium) levels within normal ranges. PTH typically raises serum calcium levels through boosting bone turnover, lowering calcium excretion in the kidneys, and promoting the production of vitamin D3 (1,25-dihydroxycholecalciferol) in the kidneys, which enhances calcium absorption in the intestines. Muscle cramps and tingling are signs of hypocalcemia-induced increased nerve and muscle excitability. The gating of voltage-sensitive sodium channels is impacted by low blood calcium, which causes the cell membrane potential to become hyperexcitable. The Trousseau phenomenon, in which the inflation of a sphygmomanometer cuff causes tetany in muscles distal to the cuff, or a positive Chvostek's sign serve as examples of this. PTH also suppresses proximal tubular phosphate reabsorption, which preserves renal phosphate excretion. Thus, hyperphosphatemia is also caused by PTH deficiency. Rare individuals with PTH resistance, or "pseudohypoparathyroidism," which results from PTH receptor mutations or related G-protein coupling, exhibit comparable clinical symptoms. The majority of the time, vitamin D supplements can be used to treat hypoparathyroidism in individuals by raising serum calcium levels.
This can be acquired as a consequence of thyroid surgery, but in this instance, it is congenital or brought on by an autoimmune condition. Hypocalcemia is brought on by the incapacity of PTH loss to keep serum calcium (and, to a lesser degree, magnesium) levels within normal ranges. PTH typically raises serum calcium levels through boosting bone turnover, lowering calcium excretion in the kidneys, and promoting the production of vitamin D3 (1,25-dihydroxycholecalciferol) in the kidneys, which enhances calcium absorption in the intestines. Muscle cramps and tingling are signs of hypocalcemia-induced increased nerve and muscle excitability. The gating of voltage-sensitive sodium channels is impacted by low blood calcium, which causes the cell membrane potential to become hyperexcitable. The Trousseau phenomenon, in which the inflation of a sphygmomanometer cuff causes tetany in muscles distal to the cuff, or a positive Chvostek's sign serve as examples of this. PTH also suppresses proximal tubular phosphate reabsorption, which preserves renal phosphate excretion. Thus, hyperphosphatemia is also caused by PTH deficiency. Rare individuals with PTH resistance, or "pseudohypoparathyroidism," which results from PTH receptor mutations or related G-protein coupling, exhibit comparable clinical symptoms. The majority of the time, vitamin D supplements can be used to treat hypoparathyroidism in individuals by raising serum calcium levels.
- Published on
Pathology - Primary Hyperparathyroidism
The signs and symptoms are related to how hypercalcemia manifests in the skeletal and urinary systems. People frequently employ the well-known acronym "bones, stones, abdominal groans, and psychiatric moans." The primary characteristic is elevated serum PTH and hypercalcemia. One parathyroid gland adenoma, located in over 80% of cases, is the cause of the illness. Similar symptoms characterize hypercalcemia associated with malignancy, which is brought on by PTH-related peptide (PTH-rp) secreted by tumors. There is feedback inhibition of endogenous PTH in these circumstances. Renal stone development is more likely in people with hypercalcemia. Loss of cortical bone commonly results in reduced bone density, which mostly affects the wrists and hips. PTH typically enhances renal calcium absorption; however, high calcium plasma concentrations also produce increased renal calcium filtration, which exceeds tubular reabsorptive capacity and results in hypercalciuria.
Low serum phosphate and elevated urine phosphate are caused by PTH's suppression of renal phosphate reabsorption. Because of the decreased activity of excitable tissues caused by hypercalcemia, bradycardia, first-degree heart block (in this instance), depressed reflexes, CNS symptoms, and decreased GI motility can all be explained. Nephrogenic DI is also brought on by hypercalcemia, which prevents vasopressin from acting at the kidney. In mild situations, high fluid intake and dietary calcium restriction are the main forms of treatment; in certain circumstances, surgical removal of one or more parathyroid glands is performed.
The signs and symptoms are related to how hypercalcemia manifests in the skeletal and urinary systems. People frequently employ the well-known acronym "bones, stones, abdominal groans, and psychiatric moans." The primary characteristic is elevated serum PTH and hypercalcemia. One parathyroid gland adenoma, located in over 80% of cases, is the cause of the illness. Similar symptoms characterize hypercalcemia associated with malignancy, which is brought on by PTH-related peptide (PTH-rp) secreted by tumors. There is feedback inhibition of endogenous PTH in these circumstances. Renal stone development is more likely in people with hypercalcemia. Loss of cortical bone commonly results in reduced bone density, which mostly affects the wrists and hips. PTH typically enhances renal calcium absorption; however, high calcium plasma concentrations also produce increased renal calcium filtration, which exceeds tubular reabsorptive capacity and results in hypercalciuria.
Low serum phosphate and elevated urine phosphate are caused by PTH's suppression of renal phosphate reabsorption. Because of the decreased activity of excitable tissues caused by hypercalcemia, bradycardia, first-degree heart block (in this instance), depressed reflexes, CNS symptoms, and decreased GI motility can all be explained. Nephrogenic DI is also brought on by hypercalcemia, which prevents vasopressin from acting at the kidney. In mild situations, high fluid intake and dietary calcium restriction are the main forms of treatment; in certain circumstances, surgical removal of one or more parathyroid glands is performed.
- Published on
Pathology - Myasthenia Gravis
Pathophysiology
At the neuromuscular junction, an antibody-mediated response is the source of the pathophysiology of MG.
Though they can potentially target muscle fibers or receptor tyrosine kinases unique to a particular muscle, antibodies are most frequently directed against acetylcholine receptors on the postsynaptic membrane. The action potential is transmitted and depolarized when ACh binds to its postsynaptic receptor in patients without MG; however, this reaction is attenuated by the antibodies generated in MG. Patients who are active tend to develop weaker with time and are more prone to weariness. Individuals may have diplopia, eyelid droop, dysphagia, dysarthria, or respiratory discomfort in addition to ocular muscle weakness. This is more common towards the end of the day. Since diaphragmatic involvement can be lethal, respiratory stabilization is the primary focus of patient care for MG patients. To raise the quantity of acetylcholine at the motor end plate, acetylcholinesterase inhibitors, such as pyridostigmine, are employed. In circumstances where symptoms are life-threatening, intravenous immunoglobulin (IVIG) or plasma exchange may be able to temporarily relieve them. For cases like this one, surgical thymoma resection is a curative treatment when thymoma on imaging is documented.
Pathophysiology
At the neuromuscular junction, an antibody-mediated response is the source of the pathophysiology of MG.
Though they can potentially target muscle fibers or receptor tyrosine kinases unique to a particular muscle, antibodies are most frequently directed against acetylcholine receptors on the postsynaptic membrane. The action potential is transmitted and depolarized when ACh binds to its postsynaptic receptor in patients without MG; however, this reaction is attenuated by the antibodies generated in MG. Patients who are active tend to develop weaker with time and are more prone to weariness. Individuals may have diplopia, eyelid droop, dysphagia, dysarthria, or respiratory discomfort in addition to ocular muscle weakness. This is more common towards the end of the day. Since diaphragmatic involvement can be lethal, respiratory stabilization is the primary focus of patient care for MG patients. To raise the quantity of acetylcholine at the motor end plate, acetylcholinesterase inhibitors, such as pyridostigmine, are employed. In circumstances where symptoms are life-threatening, intravenous immunoglobulin (IVIG) or plasma exchange may be able to temporarily relieve them. For cases like this one, surgical thymoma resection is a curative treatment when thymoma on imaging is documented.
